Company profile: UAS Labs
1.1 - Company Overview
Company description
- Provider of science-backed probiotic solutions, offering documented strains for gut, immune, and women’s health; co-development of customized formulations, including those based on L. acidophilus DDS-1; and the STRAIN TO SOLUTION process ensuring stability and safety from development to final product. Also provides The Probiotics Institute educational platform and SCIENCE by Chr. Hansen strains supported by human clinical data.
Products and services
- Probiotic Strains: UAS Labs produces science-backed, documented strains, including L. acidophilus DDS-1-based formulations, targeting gut, immune, and women's health with validated benefits for the natural products marketplace
- STRAIN TO SOLUTION™: A comprehensive, industrial-grade production system ensuring probiotic strain stability and safety from development through final product, safeguarding viability and consistency across manufacturing stages
- SCIENCE by Chr. Hansen: UAS Labs offers clinically supported, high-quality probiotic strains backed by human clinical data, targeting important health areas with documented efficacy for consumers and healthcare professionals
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to UAS Labs
ApoCell
HQ: United States
Website
- Description: Provider of clinical trial, laboratory, and data science services as a clinical research organization, with biomarker development and diagnostics capabilities, supporting diabetes, molecular diagnostics, drug development, oncology, orphan diseases, gene therapy, and neuroscience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ApoCell company profile →
Noble Pharma
HQ: United States
Website
- Description: Provider of FDA-approved contract development and manufacturing services for extremely palatable animal health products, including formulation and process development; manufacturing of soft chews, creams, ointments, suspensions, tablets, powders, and pastes; clinical supplies; GLP analytical and ICH stability services; regulatory support; packaging with serialization and child-resistant options; and technology transfer and validation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noble Pharma company profile →
Medicus Pharma
HQ: Canada
Website
- Description: Provider of biotechnology research services that accelerate life sciences and biotech companies through FDA clinical trials, via clinical development programs spanning clinical evaluation, regulatory approval, and market introduction. Through Skinject Inc., develops a dissolvable doxorubicin microneedle patch for non-melanoma skin cancer, particularly basal cell carcinoma. Pursues acquisitions and partnerships to expand its drug development pipeline.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicus Pharma company profile →
Dinamiqs
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing services for AAV and lentiviruses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dinamiqs company profile →
Artes Biotechnology
HQ: Germany
Website
- Description: Provider of biopharmaceutical production processes and CDMO services, including microbial cell line and process development, manufacturing of test and preclinical material, and vaccine development. Offers pre-developed recombinant protein processes (biosimilars, vaccines, enzymes), technology transfer and proprietary cell line licensing; supplies recombinant reagents from yeast and bacterial platforms; and develops yeast (Hansenula polymorpha) and E. coli systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artes Biotechnology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for UAS Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to UAS Labs
2.2 - Growth funds investing in similar companies to UAS Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for UAS Labs
4.2 - Public trading comparable groups for UAS Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →